ER+/HER2- BREAST CANCER

Clinical trials for ER+/HER2- BREAST CANCER explained in plain language.

Never miss a new study

Get alerted when new ER+/HER2- BREAST CANCER trials appear

Sign up with your email to follow new studies for ER+/HER2- BREAST CANCER, keep track of the ones that matter, and come back to a personal dashboard instead of checking manually.

Our safety recommendation!

By submitting, you agree to our Terms of use

Trials to join now! 1

New pill targets Tough-to-Treat breast cancer in groundbreaking trial

Disease control Recruiting now

This study is testing a new oral drug called FWD1802 for women with a specific type of advanced breast cancer (ER+/HER2-) that has spread or cannot be surgically removed. The first part of the trial aims to find a safe and effective dose. The second part will see how well the dru…

Matched conditions: ER+/HER2- BREAST CANCER

Phase: PHASE1, PHASE2 • Sponsor: Forward Pharmaceuticals Co., Ltd. • Aim: Disease control

Last updated Mar 30, 2026 14:27 UTC

ER+/HER2- BREAST CANCER

Get alerted when new ER+/HER2- BREAST CANCER trials appear

New pill targets Tough-to-Treat breast cancer in groundbreaking trial